Vaccine Preventable Diseases Surveillance

Similar documents
Invasive Bacterial Disease Surveillance Report Emerging Infections Program Minnesota Department of Health

INVASIVE BACTERIAL DISEASE SURVEILLANCE REPORT, 2016

INVASIVE BACTERIAL DISEASE SURVEILLANCE REPORT, 2010

ANNUAL SUMMARY OF INFECTIOUS DISEASES OHIO 2014

Manitoba Immunization Monitoring System (MIMS)

Implementation of International Health Regulation (2005) in the African Region

Invasive meningococcal disease in the Netherlands

FMD CONTROL IN EASTERN EUROPE

The impact of the International Health Regulations (IHR) on global health security. Thomas Hofmann WHO Regional Office for Europe Copenhagen, Denmark

Little Athletics NSW. 2018/2019 Season. Age Group Information Handbook / 1

GOV ER N ME NT OF BE RMUDA Cabinet Office Department of Statistics BERMUDA DIGEST OF STATISTICS

Domestic Hot & Cold Water Services Log Book

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*

Demographic, Social and Health Indicators for Countries of the Eastern Mediterranean

DRAFT FOR DISCUSSION. Pneumococcal Vaccine SDF AVI version 3.0. Lauren Franzel AVI Strategic Vaccine Supply Sub Team March 10, 2011

3. EXCEL FORMULAS & TABLES

Vaccine-preventable Diseases and Immunization: a WHO/EURO Update

GALLUP NEWS SERVICE GALLUP POLL SOCIAL SERIES: WORLD AFFAIRS

Self-declaration by New Zealand of its status of freedom from Equine Viral Arteritis

CME/CPE/MOC Credit Tracker

Preventive Measures and Existing Regulations for Chronic Wasting Disease in the U.S.

GALLUP NEWS SERVICE GALLUP POLL SOCIAL SERIES: WORLD AFFAIRS

GALLUP NEWS SERVICE GALLUP POLL SOCIAL SERIES: WORK AND EDUCATION

UK Integrated Behaviour Change Programmes

Reported Cases of Dracunculiasis by Country, 1972 to 2005

Bluetongue 05/10/2016 COVEPI - CESME

Veterinary Services Animal Health

Extract from TELECOMMUNICATIONS PERFORMANCE MONITORING REPORT No. 61 June Quarter 2008

HCV Ag Linearity Panel Max

US - OSHA SAFETY DATA SHEET

The OIE proposal on facilitation of international horse movement

Immediate notification report

STRATEGY (ROLL - OUT PLAN) ASA MISSION STATEMENT

Practical Training on Wildlife Surveillance for Foot-and-Mouth Disease and other contagious animal diseases affecting wildlife

Bird strikes Swedish Airspace

Useful Tools in Mosquito Surveillance

Basketball Victoria. By-laws (Participants Protection)

2018 HR & PAYROLL Deadlines

SAS Quality Scorecard August 2011

Utility Debt Securitization Authority 2013 T/TE Billed Revenues Tracking Report

Swim Ireland Masters Development Plan Ratified and adopted by the Board of Swim Ireland on 11 th December 2010

Drowning Deaths at Public Swimming Pools. Dr Bernadette Matthews Principal Research Associate Aquatic Risk and Research Life Saving Victoria

3. EXCEL FORMULAS & TABLES

African swine fever situation/control/surveillance measures applied in Slovakia

The development of Emergency Aquatic Animal Disease Response Arrangements

A Retrospective Case Study Implicating Foster Calves in a Calf Diarrhea Epidemic

The OIE proposal on facilitation of international horse movement

Yobe State Cholera Outbreak Situation Report No. 12: 1st October 2018 Yobe State Ministry of Health

EU Policy regarding management of Bluetongue disease, prevention and control measures

Are You in the Know About Construction & Renovation within Your Facility?

Ask the Vet April Stephen D. Fisch, DVM

KC Scout Kansas City s Bi-State Transportation Management Center

Report on the Global Strategy

MPTS Committee meeting, 19 September Annex A: MPTS Performance Dashboard

Infection Control Team. Section 6.1 Procedure for handling and transportation of Cadavers carrying risk of infection.

1. INTRODUCTION 2. THE PURPOSE OF THE USER GUIDE 3. CONTACT 4. INSTRUCTIONS FOR USE. 4.1 How to access the BSAC Resistance Surveillance Database

Wisconsin 511 Traveler Information Annual Usage Summary January 3, Wisconsin 511 Phone Usage ( )

Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth Trends & Forecast to 2021

Key statistics from the National Cardiac Arrest Audit 2016/17

Westmead Innovation Precinct

Vancouver 2010 Medical Services Presentation to EMS Chiefs Conference Dr. Jack Taunton May 2008

Bluetongue Disease (BT)

Vaccine Supplier Meeting Copenhagen, 3-4 April 2008 Edward Hoekstra, MD, MSc Senior Health Specialist Health Emergencies UNICEF / New York

Procedure for Handling and Transportation of Cadavers Carrying Risk of Infection

SWISS reports stable load factors

Foreign overnights in the Nordic countries 2015

MAR DASHBOARD MAR. Compliant % Breakdown Mar % Late % On-time MAR APR MAY JUN JUL AUG SEP OCT NOV DEC

What surveillance do we have for AMR?

Public Policy and Homelessness

Lake Taneycomo Fisheries Management. Shane Bush : Fisheries Management Biologist

Primary Care Commissioning Committee

2016 Crypto Outbreak & Response. Adam Holbrook, RS, REHS, NSPFI Sarah Badenhop, RS, NSPFI

Public Access Defibrillation: Where are we now? Assoc Prof Tony Walker ASM Chief Executive Officer

UPDATED SLSA WATER SAFETY POLICY AND PROCEDURE

Molecular profiling of bacterial isolates: Examples of PFGE in support to the epidemiology of VTEC human infections and source attribution

Location Publication / Responsible And Number. Controller Standards Australia

Ministry of Health and Long-Term Care. Recreational Water Protocol, 2019

Tools to Enhance Laboratory Biosafety and Biosecurity Performing Risk Assessments

Pork Outlook. Professor of Agricultural Economics. Midwest/Great Plains & Western Outlook Conference Indianapolis, August 2007

Mission of the Community Veterinary Emergency Team to LITHUANIA

KLE, HEROES, WD, ROARING, ILL,WINNERS RE,EXCITE, LO EER, MARK, PL

Dark ages to renaissance rebirth of stroke care in Wales

EQUINE RESEARCH what you need to know

SUPPORT PACK THEY RE CALLING ON YOU

ACCIDENT REPORT AND INVESTIGATION POLICY. Ratified by VDA Board: Review date:

The Onychomycosis Market (2018 Edition) September 2018

IN VITRO DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS

REFERENCE CODE GDHC0071CHR PUBLICATION DATE OCTOBER 2014 HEALTHCARE, REGULATORY AND REIMBURSEMENT LANDSCAPE ISRAEL

WEG SELECTION POLICY ENDURANCE

Acute Flaccid Paralysis (AFP) Surveillance Weekly Bulletin. Syria EWARN

January 2018 Sun Mon Tue Wed Thu Fri Sat Week 2 1 New Year's Day

DEFENSE POW/MIA ACCOUNTING AGENCY

Transmissible Spongiform Encephalopathies (TSE) D. Heim

Effective Date: January 16, 2012 Policy Number: MHC_RP0107. Revised Date: November 2, 2015 Oversight Level: Corporate

105 CMR MINIMUM STANDARDS FOR BATHING BEACHES STATE SANITARY CODE, CHAPTER VII

REPORT AND RECOMMENDATIONS FROM THE TRAINING COURSE ON THE SURVEILLANCE OF WILDLIFE DISEASES AND THE ROLE OF HUNTERS

WINNIPEG AAA HOCKEY CONCUSSION PROTOCOL SUMMARY

The London 2012 Olympic and Paralympic Games: The Medical Challenge and lessons learnt Dr Richard Budgett Chief Medical Officer LOCOG

NIHR what s new. HSR UK Conference Dr Louise Wood Director of Science, Research & Evidence Department of Health & Social

Offaly GAA Master Fixtures Plan 2018

Transcription:

Vaccine Preventable Diseases Surveillance Clinical Vaccinology Update 5 June 2015 Kylie Carville Communicable Diseases Epidemiology & Surveillance Health Protection Branch, Victorian Government Dept of Health and Human Services

Summary Surveillance of VPDs State, National, Global levels - Communicable Diseases Epidemiology and Surveillance, DHHS - Communicable Diseases Network of Australia (CDNA) - National Notifiable Diseases Surveillance Scheme (NNDSS) Successes of the national immunisation program Vaccine-preventable diseases surveillance in Victoria - Measles - Invasive meningococcal disease - Invasive pneumococcal disease - Pertussis

Communicable Diseases Epidemiology & Surveillance Monitor, prevent and control current and emerging communicable diseases within the Victorian community through the implementation of targeted strategies based on a partnership approach Legislative Framework: Public Health & Wellbeing Act 2008 Public Health & Wellbeing Regulations 2009 Emergency Management Act 1986 Quarantine Act 1908

Why follow-up vaccine preventable diseases? Public Health Followup Actions: understand the epidemiology determine the effectiveness of vaccination programs prevent secondary cases (or outbreaks) through contact tracing control outbreaks

Notifiable conditions

Victorian Infectious Diseases Epidemiology and Surveillance http://ideas.health.vic.gov.au/surveillance/tabulated-summaries.asp

Communicable Diseases Network of Australia (National Department of Health)

National Notifiable Diseases Surveillance System (NNDSS) http://www9.health.gov.au/cda/source/cda-index.cfm

Global surveillance for VPDs

National immunisation program successes

Diphtheria Notifications per 100 000 population 450 400 350 300 250 200 150 100 50 0 1932 - diphtheria vaccination commenced 1917 1921 1925 1929 1933 1937 1941 1945 1949 1953 1957 1961 1964-65 1968-69 1972 1976 1980 1984 1988 1992 1996 2000 1953 - DTP vaccination introduced

Tetanus Notifications per 100 000 population 2 1.8 1.6 1.4 1.2 1 0.8 0.6 0.4 0.2 0 1917 1921 1925 1929 1933 1937 1941 1945 1949 1953 1957 1961 1964-65 1968-69 1972 1976 1980 1984 1988 1992 1996 2000 1953 - DTP vaccination introduced

Poliomyelitis Notifications per 100 000 population 45 40 35 30 25 20 15 10 5 0 1956 - mass vaccination with IPV commenced 1917 1921 1925 1929 1933 1937 1941 1945 1949 1953 1957 1961 1964-65 1968-69 1972 1976 1980 1984 1988 1992 1996 2000 1966 - OPV introduced

Haemophilus influenzae type b disease Notifications per 100 000 population 3.50 3.00 2.50 2.00 1.50 1.00 0.50 0.00 1992 - First Hib vaccines approved 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 1993 - National Hib vaccination program commenced

Pertussis Notifications per 100 000 population 900 800 700 600 500 400 300 200 100 0 1942 - Mass vaccination with pertussis vaccine commenced 1917 1921 1925 1929 1933 1937 1941 1945 1949 1953 1957 1961 1964-65 1968-69 1972 1976 1980 1984 1988 1992 1996 2000 1953 - DTP vaccination introduced

Vaccine-preventable diseases surveillance in Victoria

Jan 01 Apr 01 Jul 01 Oct 01 Jan 02 Apr 02 Jul 02 Oct 02 Jan 03 Apr 03 Jul 03 Oct 03 Jan 04 Apr 04 Jul 04 Oct 04 Jan 05 Apr 05 Jul 05 Oct 05 Jan 06 Apr 06 Jul 06 Oct 06 Jan 07 Apr 07 Jul 07 Oct 07 Jan 08 Apr 08 Jul 08 Oct 08 Jan 09 Apr 09 Jul 09 Oct 09 Jan 10 Apr 10 Jul 10 Oct 10 Jan 11 Apr 11 Jul 11 Oct 11 Jan 12 Apr 12 Jul 12 Oct 12 Jan 13 Apr 13 Jul 13 Oct 13 Jan 14 Apr 14 Jul 14 Oct 14 Jan 15 Apr 15 Number of notified cases Measles - cases 60 Notified cases of measles by month, Victoria, 1 Jan 2001 to 27 May 2015 50 40 30 20 10 0 Month of notification

Measles follow up Group A disease - urgent notification by telephone - Interview treating doctor - Arrange testing at Reference Lab confirmation required - Ascertain vaccination status - Determine onset of illness - Interview patient for thorough history of illness, travel - Perform contact tracing to prevent secondary cases - Vaccinate and/or arrange immunoglobulin - Provide information to case/contacts - Exclude cases/unimmunised contacts from school/work

Measles cluster 21M Burwood East Rash onset 1 Mar Travel: India 27M Box Hill South Rash onset 17 Mar Same flight Unknown intermediary 25F Northcote Rash onset 6 Apr No travel 21M Greensborough Rash onset 8 Apr No travel 39M Roxburgh Park Rash onset 9 Apr No travel 29F Oak Park Rash onset 9 Apr No travel 35M Malvern Rash onset 18 Apr No travel 41F Roxburgh Park Rash onset 21 Apr No travel 30M Oak Park Rash onset 21 Apr No travel

14 12 10 8 6 4 2 0 (2008) 1 59 (2009) 1 59 (2010) 1 59 (2011) 1 59 (2012) 1 59 13 17 21 25 29 33 37 41 45 49 13 17 21 25 29 33 37 41 45 49 13 17 21 25 29 33 37 41 45 49 13 17 21 25 29 33 37 41 45 49 13 17 21 25 29 33 37 41 45 49 Number of cases genotyped Weekly distribution of measles genotypes identified at VIDRL 2008-2012 Genotype data reviewed 354 cases positive by RT-PCR 293 cases genotyped as wt measles; 16 vaccine strains Measles detected all year round Multiple genotypes detected B3 D4 D5 D8 D9 G3 H1 Untypable Untyped (Year) Week number Slide from Thomas Tran (VIDRL), presented at Communicable Disease Control Conference, Brisbane, 1-2 June 2015

Number of notified cases Invasive meningococcal disease Confirmed and probable invasive meningococcal disease notifications by serogroup, Victoria, 1 Jan 1995 to 3 Jun 2015 250 200 MenCCV 12mo dose (from Jan 2003) catch-up 1-19yo's (2003-2006) Unknown 29E Group Y Group W135 Group C Group B Group A 150 100 50 0 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015* Year of notification

Clearance antibiotics for meningococcal disease CDNA National Guidelines for Public Health Units - Updated April 2015 Clearance antibiotic use - Childcare: at least 4 hours/day on average or 20 hours in total in the 7 days prior to the onset of the case s illness. - Healthcare workers: only those who have come into direct contact with the nasopharyngeal secretions of a case during a procedure such as intubation without wearing a surgical mask or mouth-to-mouth resuscitation http://www.health.gov.au/internet/main/publishing.nsf/content/cdna-song-imd.htm

Invasive pneumococcal disease (IPD)

Number of cases IPD notifications aged <5 years, by vaccine type and date of notification, Victoria 25 13 valent vaccine Non-typable 20 15 7 valent vaccine Unknown Non-conjugate vaccine ST 13vPCV excl 7vPCV 7vPCV 10 5 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Quarter and year of notification

Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Number of cases Cases of IPD aged <5 years caused by sertoypes contained within the 13- valent conjugate vaccine (excluding 7-valent serotypes) 16 13 valent vaccine 14 12 7 valent vaccine 10 8 6 4 7F 6A 19A 4 3 1 2 0 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Quarter and year of notification

13v serotypes in 65 years and older 7 valent PCV on NIP 13 valent PCV on NIP

Jan 97 Apr 97 Jul 97 Oct 97 Jan 98 Apr 98 Jul 98 Oct 98 Jan 99 Apr 99 Jul 99 Oct 99 Jan 00 Apr 00 Jul 00 Oct 00 Jan 01 Apr 01 Jul 01 Oct 01 Jan 02 Apr 02 Jul 02 Oct 02 Jan 03 Apr 03 Jul 03 Oct 03 Jan 04 Apr 04 Jul 04 Oct 04 Jan 05 Apr 05 Jul 05 Oct 05 Jan 06 Apr 06 Jul 06 Oct 06 Jan 07 Apr 07 Jul 07 Oct 07 Jan 08 Apr 08 Jul 08 Oct 08 Jan 09 Apr 09 Jul 09 Oct 09 Jan 10 Apr 10 Jul 10 Oct 10 Jan 11 Apr 11 Jul 11 Oct 11 Jan 12 Apr 12 Jul 12 Oct 12 Jan 13 Apr 13 Jul 13 Oct 13 Jan 14 Apr 14 Jul 14 Oct 14 Jan 15 Apr 15 Number of notified cases Pertussis 1200 1000 800 25+ 18 to <25 15 to <18 5 to <15 1 to <5 <1 Notified cases of pertussis by month and age group, Victoria, 1 January 1997 to 26 May 2015 600 400 200 0 Month of notification

Pertussis cases aged <6mo

Pertussis notifications by age group

Further information? www.ideas.health.vic.gov.au www.health.vic.gov.au/immunisation Communicable Diseases Phone: 1300 651 160 (Afterhours): 1300 790 733

Acknowledgements Laboratory notifiers primary labs Medical practitioner notifiers Reference laboratories: - Microbiological Diagnostic Unit (MDU) - Victorian Infectious Diseases Reference Laboratory (VIDRL) Public Health Officers and Immunisation staff in the Health Protection Branch, Department of Health